AMETEK Names Kurtis L. Goos, Vice President & General Manager, Engineered Medical Components - WTNZ FOX 43 Knoxville, TN

AMETEK Names Kurtis L. Goos, Vice President & General Manager, Engineered Medical Components

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE AMETEK, Inc.

BERWYN, Pa., July 25, 2014 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced the appointment of Kurtis L. Goos as Vice President and General Manager, Engineered Medical Components, within AMETEK's Engineered Materials, Interconnects and Packaging (EMIP) Division.

"I am pleased that Kurt has joined AMETEK.  He has extensive general management and business development experience, especially in the medical device industry, and we expect him to make important contributions to the continued growth and success of our medical components businesses," commented Frank S. Hermance, AMETEK Chairman and Chief Executive Officer.

Mr. Goos joins AMETEK from Carestream Health, a global provider of medical imaging systems and healthcare information technology solutions, where he most recently was Worldwide General Manager of Digital Output Solutions.  Prior to that, he had responsibility for Carestream's worldwide Women's Health Care business.  He also has held a number of general management, marketing and business development positions with several leading medical device manufacturers, including the Sorin Group, St. Jude Medical and Medtronic.

Mr. Goos has a Bachelor's degree in Marketing and Business from Moorhead State University and a Master's degree in Business Administration from the University of St. Thomas.

Corporate Profile
AMETEK is a leading global manufacturer of electronic instruments and electro-mechanical devices with 2013 sales of $3.6 billion. AMETEK's Corporate Growth Plan is based on Four Key Strategies: Operational Excellence, Strategic Acquisitions, Global & Market Expansion and New Products.  AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. The common stock of AMETEK is a component of the S&P 500 Index.

Forward-looking Information
Statements in this news release relating to future events, such as AMETEK's expected business and financial performance are "forward-looking statements."  Forward-looking statements are subject to various factors and uncertainties that may cause actual results to differ significantly from expectations. These factors and uncertainties include AMETEK's ability to consummate and successfully integrate future acquisitions; risks associated with international sales and operations; AMETEK's ability to successfully develop new products, open new facilities or transfer product lines; the price and availability of raw materials; compliance with government regulations, including environmental regulations; changes in the competitive environment or the effects of competition in our markets; the ability to maintain adequate liquidity and financing sources; and general economic conditions affecting the industries we serve.  A detailed discussion of these and other factors that may affect our future results is contained in AMETEK's filings with the U.S. Securities and Exchange Commission, including its most recent reports on Form 10-K, 10-Q and 8-K.  AMETEK disclaims any intention or obligation to update or revise any forward-looking statements.

Contact: Kevin Coleman (610) 889-5247

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow

9000 Executive Park Drive
Building D Suite 300
Knoxville, TN 37923

Phone #: 865-693-4343
Fax #'s:
General: 865-691-6904
Sales: 865-691-6770
Traffic: 865-691-7527

FCC Public File
publicfile@wtnzfox43.com
865-693-4343
EEO Report
Closed Captioning

Powered by WorldNow
All content © Copyright 2000 - 2012 WorldNow and WTNZ. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.